An Extension Clinical Study of the Efficacy and Safety of BCD-132 in Patients With Multiple Sclerosis Who Previously Received Therapy in Clinical Studies of JSC BIOCAD
NCT06987851
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
44
Enrollment
INDUSTRY
Sponsor class
Conditions
Multiple Sclerosis
Interventions
BIOLOGICAL:
Divozilimab
Sponsor
Biocad